title: Canadian Consensus Conference on menopause, 2006 update.
abstract: OBJECTIVE
  To provide guidelines for health care providers on the management of menopause in asymptomatic healthy women as well as in women presenting with vasomotor symptoms, urogenital, sexual, and mood and memory concerns and on specific medical considerations, and cardiovascular and cancer issues.
  
  
  RESULTS
  Prescription medications, complementary and alternative medicine (CAM), and lifestyle interventions are presented according to their efficacy in treating menopausal symptoms.
  
  
  METHODS
  MEDLINE and the Cochrane database were searched for articles from March 2001 to April 2005 in English on subjects related to menopause, menopausal symptoms, urogenital and sexual health, mood and memory, hormone therapy, CAM, and on specific medical considerations that affect the decision of which intervention to choose.
  
  
  METHODS
  The quality of evidence is rated using the criteria described in the report of the Canadian Task Force on the Periodic Health Examination. Recommendations for practice are ranked according to the method described in this report (see Table 1).
  
  
  BACKGROUND
  The development of this consensus guideline was supported by unrestricted educational grants from Berlex Canada Inc, Lilly Canada, Merck Frosst, Novartis, Novogen, Novo Nordisk, Proctor and Gamble, Schering Canada, and Wyeth Canada.
authors.affiliation: Montreal QC.
authors.forename: Serge
authors.initials: S
authors.lastname: Bélisle
authors.forename: Jennifer
authors.initials: J
authors.lastname: Blake
authors.forename: Rosemary
authors.initials: R
authors.lastname: Basson
authors.forename: Sophie
authors.initials: S
authors.lastname: Desindes
authors.forename: Gillian
authors.initials: G
authors.lastname: Graves
authors.forename: Sophie
authors.initials: S
authors.lastname: Grigoriadis
authors.forename: Shawna
authors.initials: S
authors.lastname: Johnston
authors.forename: André
authors.initials: A
authors.lastname: Lalonde
authors.forename: Christina
authors.initials: C
authors.lastname: Mills
authors.forename: Lynn
authors.initials: L
authors.lastname: Nash
authors.forename: Robert
authors.initials: R
authors.lastname: Reid
authors.forename: Timothy
authors.initials: T
authors.lastname: Rowe
authors.forename: Vyta
authors.initials: V
authors.lastname: Senikas
authors.forename: Vyta
authors.initials: V
authors.lastname: Senikas
authors.forename: Michele
authors.initials: M
authors.lastname: Turek
mesh_terms: D000339:Affect; D000368:Aged; D001943:Breast Neoplasms / Q000628:therapy; D002318:Cardiovascular Diseases / Q000628:therapy; D000529:Complementary Therapies; D004032:Diet; D004700:Endocrine System Diseases / Q000628:therapy; D004967:Estrogens / Q000502:physiology / Q000627:therapeutic use; D005260:Female; D052776:Female Urogenital Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D020249:Hormone Replacement Therapy; D006801:Humans; D008019:Life Style; D008568:Memory; D008593:Menopause / Q000502:physiology; D008659:Metabolic Diseases / Q000628:therapy; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy; D011372:Progestins / Q000627:therapeutic use; D012735:Sexual Dysfunction, Physiological / Q000209:etiology / Q000628:therapy; D019529:Sexuality / Q000502:physiology; D012890:Sleep; D014549:Urinary Incontinence / Q000628:therapy
chemical_list: D004967:Estrogens; D011372:Progestins